After having worked for the US based pharmaceutical company Armour, Dr. Gernot Klotz joined Bayer in various business sections (pharmaceutical, animal health and crop protection/product development).
Since February 2007, G. Klotz has been seconded as the Executive Director for Research and Innovation for the European Chemical Industry Council (Cefic). Specific key areas of responsibility are innovation (technology development, innovation policies, societal acceptance of new technologies and products), emerging science-policy issues (Health and Environment) and the Cefic Long Range Research Initiative (LRI) as well as managing the Cefic Research and Innovation Board. He is also responsible for the EU Technology Platform for Sustainable Chemistry (SusChem) and a Board Member of A.SPIRE Public Private Partnership.
- Klotz has been called on to various advisory and steering committees at OECD, WHO and EU Commission level in areas like innovation, technology development, testing and assessment, impact on environment and health. He is chairing the Horizon 2020 Advisory Group for « Leadership in Enabling Industrial Technologies, Nanotechnologies, Advanced Materials and Advanced Manufacturing and Processing (« LEIT-NMBP »). Within the High level group on Key enabling technologies (HLG KETs), he is leading the working group linking “societal” challenges with technologies in the EC Innovation area. He is also a member of the Governing Board of Knowledge4Innovation (K4I).